Cellomics International

Cellomics is a leading biotech company based in the Greater-Bay-Area, focusing on the development and commercialization of liquid biopsy products and services for early screening and disease management of cancer. With proprietary microfluidics and nucleic acid detection technology, we offer comprehensive liquid biopsy solutions for precision oncolo... gy which only require one blood draw of 4 ml. Our innovative products for circulating tumour cell enrichment and genetic analysis are manufactured in ISO13485 & ISO9001- certified facilities and are approved for clinical use in China and European markets. Additionally, with the use of our technology we aid doctors to test drug sensitivity and help patients identify the most appropriate medication. Cellomics has obtained over 10 million HKD in funding from the HK government, as well as raising over 70 million HKD (10 million USD) in private/institutional funding. Cellomics aspires to become a global leader in liquid biopsy and precision medicine, and collaborating with international partners to help doctors and patients in winning the war against cancer.Read More